Adenylate kinase deficiency and malignant hyperthermia

Area of Science:

• Biochemistry
• Genetics
• Anesthesiology

Background:

• Malignant hyperthermia (MH) is a severe pharmacogenetic disorder of skeletal muscle.
• Previous reports suggested a potential link between muscle adenylate kinase deficiency and MH susceptibility.

Purpose of the Study:

• To investigate whether muscle adenylate kinase deficiency serves as a biochemical marker for susceptibility to malignant hyperthermia.
• To determine if MH-susceptible individuals share this specific enzyme abnormality.

Main Methods:

• Adenylate kinase activity and electrophoretic mobility were measured in muscle tissue.
• Samples were analyzed from three survivors of malignant hyperthermia and five relatives with positive caffeine contracture tests.
• Comparison was made against four control muscle tissue samples.

Main Results:

• No significant differences were observed in either the activity or electrophoretic mobility of muscle adenylate kinase between MH-susceptible individuals and controls.
• The findings indicate that muscle adenylate kinase deficiency is not a consistent biochemical feature among individuals susceptible to MH.

Conclusions:

• Muscle adenylate kinase deficiency is not a shared biochemical abnormality in all individuals susceptible to malignant hyperthermia.
• This enzyme deficiency cannot be used as a universal biochemical marker for MH susceptibility.